{"organizations": [], "uuid": "9e8bdfdbbf335cf23daddba166c9319394d191b6", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "", "site_section": "http://www.reuters.com/finance/personal-finance", "section_title": "Wealth, Personal Finance &amp; Money | Reuters.com", "url": "http://www.reuters.com/article/2015/09/24/idUSL4N11U3P120150924", "country": "US", "title": "BRIEF-Livzon Pharma plans industry fund, unit in alliance with Epirus Switzerland", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "BRIEF-Livzon Pharma plans industry fund, unit in alliance with Epirus Switzerland | Reuters", "spam_score": 0.0, "site_type": "news", "published": "2015-09-24T16:20:00.000+03:00", "replies_count": 0, "uuid": "9e8bdfdbbf335cf23daddba166c9319394d191b6"}, "author": "Reuters", "url": "http://www.reuters.com/article/2015/09/24/idUSL4N11U3P120150924", "ord_in_thread": 0, "title": "BRIEF-Livzon Pharma plans industry fund, unit in alliance with Epirus Switzerland", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "Sept 24 Livzon Pharmaceutical Group Inc\n* Says unit Livzon Mabpharm signs collaboration agreement with Switzerland's Epirus Switzerland\n* Says plans to set up industry fund worth 500 million yuan ($78.35 million) with partner\nSource text in Chinese: bit.ly/1iy9eAM ; bit.ly/1VcnM5B\nFurther company coverage: ($1 = 6.3818 Chinese yuan renminbi) (Reporting by Hong Kong and Singapore newsrooms)", "external_links": ["http://bit.ly/1iy9eAM", "http://bit.ly/1VcnM5B"], "published": "2015-09-24T16:20:00.000+03:00", "crawled": "2015-09-24T15:22:37.976+03:00", "highlightTitle": ""}